1-234609329-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000366609.4(IRF2BP2):c.166G>A(p.Ala56Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000262 in 1,524,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A56A) has been classified as Likely benign.
Frequency
Consequence
ENST00000366609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF2BP2 | NM_182972.3 | c.166G>A | p.Ala56Thr | missense_variant | 1/2 | ENST00000366609.4 | NP_892017.2 | |
IRF2BP2 | NM_001077397.1 | c.166G>A | p.Ala56Thr | missense_variant | 1/2 | NP_001070865.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF2BP2 | ENST00000366609.4 | c.166G>A | p.Ala56Thr | missense_variant | 1/2 | 1 | NM_182972.3 | ENSP00000355568.3 | ||
IRF2BP2 | ENST00000366610.7 | c.166G>A | p.Ala56Thr | missense_variant | 1/2 | 1 | ENSP00000355569.3 | |||
ENSG00000228830 | ENST00000436039.1 | n.631-92C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151430Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.00000219 AC: 3AN: 1372986Hom.: 0 Cov.: 34 AF XY: 0.00000294 AC XY: 2AN XY: 679642
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151430Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 73938
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with IRF2BP2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 56 of the IRF2BP2 protein (p.Ala56Thr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at